RSS-Feed abonnieren

DOI: 10.1055/s-0042-1757637
Experience with Congenital Adrenal Hyperplasia in Tripoli Children's Hospital, Libya
Funding and Sponsorship None.

Abstract
Congenital adrenal hyperplasia (CAH) denotes a group of autosomal recessive disorders. Its clinical spectrum varies from classical CAH (CCAH) to nonclassic CAH. It may be a simple virilizing form or salt-wasting type. The study described the clinical presentation, treatment modalities, and sequelae of CAH, including its effect on patient growth during long-term follow-up. A case series study was conducted on patients with CAH who attended and followed up in the Endocrine Clinic in Tripoli Children's Hospital from January 1, 2000 to December 31, 2018. The presentation and the last visit captured demographic and clinical features at the time of diagnosis, types of CAH (classical vs. nonclassical), investigations, treatment details, and height. All patients underwent biochemical testing and hormonal assay, including adrenocorticotropin hormone (ACTH), 17-hydroxyprogesterone (17-OHP), and plasma renin activity (PRA) levels before and after treatment. Fifty-eight patients were included; 38 (65.5.2%) were female, age at presentation in 94.8% ranged between 1 day and 10 years, with a mean age of 2.3 ± 1.1 years. Ambiguous genitalia was the presenting feature in 55.2 and 84% of total and female patients, respectively. Salt wasting was present in 37.9%. Of 32 female patients with ambiguous genitalia, only 11 (34.4%) out of them and 19% of all patients had a surgical correction. The mean and standard deviation of height at diagnosis was 78.327 + 31.070, and the last visit after treatment was 108.345 + 31.781. The relation between the date of birth and height throughout follow-up for those at last visit with age ranges from 13 to 18 years old, their mean and standard deviation of height was 135.650 + 29.286, and for patients who were less than13 years at last visit, the mean and standard deviation of height was 101.079 + 32.121; p-value = 0.003. The Z-scores were calculated and showed that about eight patients were positively above the average mean of the population. Biochemical disturbances were improved after treatment, including sodium, potassium, and glucose in CCAH type; p-value < 0.001. Hormonal findings included levels of ACTH, 17-OHP, and PRA; all levels were reduced with treatment; p-value < 0.001. In this single-center series, most of our patients with biochemical and hormonal abnormalities were normalized with hormonal replacement and limited surgical correction of females with ambiguous genitalia.
Authors' Contribution
Both authors contributed substantially to the study's design and conduct, drafting and revising the manuscript, and approval of its final version.
Compliance with Ethical Principles
The Tripoli Children's Hospital Committee approved the study for scientific research, and permission was also obtained from the research and consulting department at the Faculty of Medicine, University of Tripoli for publication. Verbal informed consent was obtained from all participants during their follow-up at the clinic. Data confidentiality was maintained throughout the study, and any resulting publication was anonymous.
Publikationsverlauf
Artikel online veröffentlicht:
02. Dezember 2022
© 2022. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Turcu AF, Auchus RJ. The next 150 years of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 2015; 153: 63-71
- 2 Wilson TA, Bowden SA. Congenital adrenal hyperplasia. October 2020. Accessed September 20, 2022, at: https://emedicine.medscape.com/article/919218-overview
- 3 Livadas S, Bothou C. Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach. Front Endocrinol (Lausanne) 2019; 10: 366
- 4 Dayal D, Aggarwal A, Seetharaman K, Muthuvel B. Central precocious puberty complicating congenital adrenal hyperplasia: North Indian experience. Indian J Endocrinol Metab 2018; 22 (06) 858-859
- 5 Oyenusi EE, Oduwole AO, Okorie OO, Adekoya AO, Nwaogu NT, Asafo-Agyei SB. Congenital adrenal hyperplasia at the Lagos University Teaching Hospital: a 10-year review. Journal of Clinical Sciences 2016; 13 (04) 178
- 6 Osifo OD, Nwashili NJ. Congenital adrenal hyperplasia: challenges of management in a developing country. Afr J Urol 2008; 14: 138-142
- 7 Famuyiwa OO. Problems and challenges in the practice of endocrinology in a developing country – an overview. Niger Med Pract 1990; 20: 3-6
- 8 Onyiriuka AN, Shaibu M. 11-Beta-hydroxylase deficient congenital adrenal hyperplasia in a toddler: clinical presentation and management challenges in a developing country. J Nepal Paediatr Soc 2013; 33: 48-51
- 9 Loche S, New M. Congenital Adrenal Hyperplasia: Female Pseudohermaphroditism and Virilization: Glob. libr. women's med. 2008
- 10 Turcu AF, Auchus RJ. Novel treatment strategies in congenital adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes 2016; 23 (03) 225-232
- 11 Nwosu BU, Lee MM. Evaluation of short and tall stature in children. Am Fam Physician 2008; 78 (05) 597-604
- 12 Belinda G, Vinay D, Moolechery J. et al. Congenital adrenal hyperplasia - experience from a tertiary centre in South India. Indian J Endocrinol Metab 2012; 16 (Suppl 2): S385-S386
- 13 Sun J, Steffen LM, Ma C, Liang Y, Xi B. Definition of pediatric hypertension: are blood pressure measurements on three separate occasions necessary?. Hypertens Res 2017; 40 (05) 496-503
- 14 Hagedoorn NN, Zachariasse JM, Moll HA. A comparison of clinical paediatric guidelines for hypotension with population-based lower centiles: a systematic review. Crit Care 2019; 23 (01) 380
- 15 Maiti A, Chatterjee S. Congenital adrenal hyperplasia: an Indian experience. J Paediatr Child Health 2011; 47 (12) 883-887
- 16 Bakhit AM, Mohammad HA, Metwalley KA. A descriptive study on children with congenital adrenal hyperplasia attending Assiut University Children Hospital. J Clin Mol Endocrinol 2017; 2: 2
- 17 Al Shaikh A, AlGhanmi Y, Awidah S, Bahha A, Ahmed ME, Soliman AT. Clinical patterns and linear growth in children with congenital adrenal hyperplasia, an 11-year experience. Indian J Endocrinol Metab 2019; 23 (03) 298-306
- 18 Bhanji R, Khan AH, Balouch IL, Sabir S, Nazir Z, Billoo AG. Profile of children with congenital adrenal hyperplasia–a hospital study. J Pak Med Assoc 2004; 54 (10) 509-512
- 19 Vakili R. Congenital adrenal hyperplasia in North-East of Iran: a review of 47 patients and the role of parental consanguinity in disease occurrence. Med J Islam Repub Iran 2002; 16: 75-78
- 20 Al-Jurayyan NA, Osman HA. The increased prevalence of congenital adrenal hyperplasia in Saudi Arabia: the role of consanguinity and multiple siblings involvement. Eur J Res Med Sci 2015; 3: 31-34
- 21 American Academy of Pediatrics. Committee on Genetics. Evaluation of the newborn with developmental anomalies of the external genitalia. Pediatrics 2000; 106 (1 Pt 1): 138-142
- 22 Sowande OA, Adejuyigbe O. Management of ambiguous genitalia in Ile Ife, Nigeria: challenges and outcome. Afr J Paediatr Surg 2009; 6 (01) 14-18
- 23 Göllü G, Yildiz RV, Bingol-Kologlu M. et al. Ambiguous genitalia: an overview of 17 years' experience. J Pediatr Surg 2007; 42 (05) 840-844
- 24 Joshi RR, Rao S, Desai M. Etiology and clinical profile of ambiguous genitalia an overview of 10 years experience. Indian Pediatr 2006; 43 (11) 974-979
- 25 Maccabee-Ryaboy N, Thomas W, Kyllo J. et al. Hypertension in children with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2016; 85 (04) 528-534
- 26 Canlas JF, Ponmani C. Congenital adrenal hyperplasia with salt-wasting crisis and arrhythmia: a case study. BMJ Case Rep 2019; 12 (01) e227565
- 27 Lin-Su K, Harbison MD, Lekarev O, Vogiatzi MG, New MI. Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab 2011; 96 (06) 1710-1717
- 28 Dixon J, Carson DA. 30 year review of congenital adrenal hyperplasia in Northern Ireland. Arch Dis Child 2012; 97 (01) A117